Literature DB >> 16632763

Caries-inhibiting effect of chlorhexidine varnish in pits and fissures.

Q Zhang1, M A van 't Hof, G J Truin, E M Bronkhorst, W H van Palenstein Helderman.   

Abstract

Evidence regarding the caries-inhibiting effect of chlorhexidine varnish is inconclusive. This study investigated the caries-inhibiting effect of the varnish EC40 on pits and fissures of first permanent molars. A two-year randomized controlled trial was carried out among 461 six- to seven-year-old children. In a split-mouth design, one group of molars received EC40 at baseline, 6, 12, and 18 months, and another group at baseline, 3, 12, and 15 months. Control molars did not receive EC40. Adherence to the treatment protocol was good. The dropout rate was 17%. Blinded examiners performed dental examinations. The caries-inhibiting effects of the two EC40 application schemes were comparable. The prevented fraction of caries was 25% (95%CI, 1%, 49%, p = 0.04) after 2 years and 9% (95%CI, -11%, 29%, p = 0.20) one year after termination of the trial, suggesting a short-term benefit from the use of EC40. The efficiency of EC40 is questionable in low-caries-incidence child populations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16632763     DOI: 10.1177/154405910608500514

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  2 in total

1.  A novel sustained-release clotrimazole varnish for local treatment of oral candidiasis.

Authors:  Rakefet Czerninski; Sagi Sivan; Doron Steinberg; Irith Gati; Leonid Kagan; Michael Friedman
Journal:  Clin Oral Investig       Date:  2009-04-29       Impact factor: 3.573

2.  Antimicrobial Efficacy of Propolis-Containing Varnish in Children: A Randomized and Double-Blind Clinical Trial.

Authors:  Edilson Martins Rodrigues Neto; Lídia Audrey Rocha Valadas; Patrícia Leal Dantas Lobo; Said Gonçalves da Cruz Fonseca; Francisco Vagnaldo Fechine; Mara Assef Leitão Lotif; Mary Anne Medeiros Bandeira; Julia Fontinele Mendonça; Karianne Marques de Mendonça; Marta Maria de França Fonteles
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-26       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.